The FDA's approach to cataloging new drugs by characteristics is called what?

The FDA's approach to cataloging new drugs by characteristics is called what?

• A. Numerical Classification
• B. FDA Classification
• C. Letter Classification
• D. New Medication Development

Answer: (B)

Grouping drugs by shared characteristics is how regulators organize medicines. This approach, sorting drugs according to properties like mechanism of action, therapeutic use, or chemical structure, helps clinicians and researchers quickly understand a drug’s role and behavior. The FDA Classification name fits this idea because it describes organizing new medicines into categories based on their characteristics, making it the best descriptor for how the FDA catalogs new drugs. The other terms don’t match: numerical or letter labeling would imply a labeling scheme that isn’t used for categorizing drugs, and new medication development refers to the process of creating drugs rather than how they are organized once they exist.

Grouping drugs by shared characteristics is how regulators organize medicines. This approach, sorting drugs according to properties like mechanism of action, therapeutic use, or chemical structure, helps clinicians and researchers quickly understand a drug’s role and behavior. The FDA Classification name fits this idea because it describes organizing new medicines into categories based on their characteristics, making it the best descriptor for how the FDA catalogs new drugs. The other terms don’t match: numerical or letter labeling would imply a labeling scheme that isn’t used for categorizing drugs, and new medication development refers to the process of creating drugs rather than how they are organized once they exist.